LSPedia 的全球序列化系列
序列化不是一刀切的。由于美国、欧盟、亚洲和中东的规定各不相同,公司必须应对复杂的要求网络。您为全球合规做好准备了吗?
.png)
欢迎来到 LspEdia,在这里,创新与奉献精神相结合。
如果你热衷于有所作为并在协作环境中茁壮成长,LspEdia 就是你的不二之选。

序列化不是一刀切的。由于美国、欧盟、亚洲和中东的规定各不相同,公司必须应对复杂的要求网络。您为全球合规做好准备了吗?
如果你热衷于有所作为并在协作环境中茁壮成长,LspEdia 就是你的不二之选。
在韩国制药行业的动态领域,遵守可追溯性要求是负责任和安全的制药实践的基石。韩国食品药品安全部(MFDS)制定了严格的法规,以确保以韩国药品信息服务系统为中心的供应链中药品的安全性、真实性和可追溯性。
产品必须带有唯一的识别码和序列化,从而可以在整个供应链中进行精确的跟踪和追踪。这种序列化充当数字指纹,确保药品的真实性。
公司必须仔细报告各个阶段的数据,包括生产、分销和销售。这种全面的报告系统使监管机构能够监控药品的流动,迅速发现任何违规行为。
监管框架得到严格的合规措施的支持。定期进行检查和审计,以评估对可追溯性法规的遵守情况,违规行为可能会导致处罚和监管行动。
韩国的可追溯性要求通常与国际标准一致,促进了互操作性并促进了药品的全球贸易。
Our team of compliance experts possesses in-depth knowledge of iTS and Turkish pharmaceutical regulations. From serialization strategies to data reporting, we guide your organization through the intricacies of compliance, ensuring a smooth and informed journey.
Leverage our state-of-the-art compliance solution, designed to integrate seamlessly with iTS requirements. Our technology ensures accuracy, efficiency, and real-time visibility, empowering your organization to meet and exceed compliance expectations.
Compliance is not just about meeting today's standards; it's about preparing for the future. Our solution is designed to evolve with regulatory changes, ensuring that your organization remains at the forefront of compliance in the dynamic Turkish pharmaceutical landscape.
We believe in transparent collaboration. Partner with us, and we'll work closely with your team to implement and maintain compliance measures. Our goal is to build a resilient, compliant, and future-ready pharmaceutical supply chain together.
作为一家在韩国运营的制药实体,了解和接受这些可追溯性要求至关重要。驾驭这种监管格局需要采取积极主动的方法,利用尖端技术和战略合作伙伴关系来确保合规性、透明度和最高的患者安全标准。随时了解情况,保持合规——助力您的制药业务在韩国监管的制药环境中取得成功。
We invite you to learn more about how LSPedia can support your compliance and supply chain needs. For more information about our solutions, partnership opportunities, or to speak with one of our experts.
Stay connected with us on social media and subscribe to our newsletter to receive the latest updates, insights, and innovations from LSPedia.